Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 16

1.

Paraganglioma of the pancreas: a potentially functional and malignant tumor.

Zhang L, Liao Q, Hu Y, Zhao Y.

World J Surg Oncol. 2014 Jul 17;12:218. doi: 10.1186/1477-7819-12-218.

PMID:
25030833
[PubMed - in process]
Free PMC Article
2.

A catecholamine-secreting skull base sinonasal paraganglioma presenting with labile hypertension in a patient with previously undiagnosed genetic mutation.

Hahn S, Palmer JN, Adappa ND.

J Neurol Surg Rep. 2012 Oct;73(1):19-24. doi: 10.1055/s-0032-1301408. Epub 2012 Feb 17.

PMID:
23946921
[PubMed]
Free PMC Article
3.

Molecular and therapeutic advances in the diagnosis and management of malignant pheochromocytomas and paragangliomas.

Lowery AJ, Walsh S, McDermott EW, Prichard RS.

Oncologist. 2013;18(4):391-407. doi: 10.1634/theoncologist.2012-0410. Epub 2013 Apr 10. Review.

PMID:
23576482
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Malignant abdominal paraganglioma presenting as a giant intra-peritoneal mass.

Moslemi MK, Abolhasani M, Vafaeimanesh J.

Int J Surg Case Rep. 2012;3(11):537-40. doi: 10.1016/j.ijscr.2012.07.007. Epub 2012 Jul 28.

PMID:
22902800
[PubMed]
Free PMC Article
5.

Updated and new perspectives on diagnosis, prognosis, and therapy of malignant pheochromocytoma/paraganglioma.

Parenti G, Zampetti B, Rapizzi E, Ercolino T, Giachè V, Mannelli M.

J Oncol. 2012;2012:872713. doi: 10.1155/2012/872713. Epub 2012 Jul 17.

PMID:
22851969
[PubMed]
Free PMC Article
6.

Malignant paraganglioma of the mesentery: a case report and review of literature.

Chetrit M, Dubé P, Royal V, Leblanc G, Sideris L.

World J Surg Oncol. 2012 Feb 23;10:46. doi: 10.1186/1477-7819-10-46. Review.

PMID:
22360863
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Clinical benefits of systemic chemotherapy for patients with metastatic pheochromocytomas or sympathetic extra-adrenal paragangliomas: insights from the largest single-institutional experience.

Ayala-Ramirez M, Feng L, Habra MA, Rich T, Dickson PV, Perrier N, Phan A, Waguespack S, Patel S, Jimenez C.

Cancer. 2012 Jun 1;118(11):2804-12. doi: 10.1002/cncr.26577. Epub 2011 Oct 17.

PMID:
22006217
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Metastatic paraganglioma.

Fliedner SM, Lehnert H, Pacak K.

Semin Oncol. 2010 Dec;37(6):627-37. doi: 10.1053/j.seminoncol.2010.10.017. Review. Erratum in: Semin Oncol. 2011 Jun;38(3):467.

PMID:
21167381
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Increased uptake of [¹²³I]meta-iodobenzylguanidine, [¹⁸F]fluorodopamine, and [³H]norepinephrine in mouse pheochromocytoma cells and tumors after treatment with the histone deacetylase inhibitors.

Martiniova L, Perera SM, Brouwers FM, Alesci S, Abu-Asab M, Marvelle AF, Kiesewetter DO, Thomasson D, Morris JC, Kvetnansky R, Tischler AS, Reynolds JC, Fojo AT, Pacak K.

Endocr Relat Cancer. 2011 Jan 13;18(1):143-57. doi: 10.1677/ERC-10-0090. Print 2011 Feb.

PMID:
21098082
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Malignant head and neck paragangliomas: is there an optimal treatment strategy?

Moskovic DJ, Smolarz JR, Stanley D, Jimenez C, Williams MD, Hanna EY, Kupferman ME.

Head Neck Oncol. 2010 Sep 23;2:23. doi: 10.1186/1758-3284-2-23.

PMID:
20863367
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

A decade of clinical experience with extra-adrenal paragangliomas of retroperitoneum: Report of 67 cases and a literature review.

Wen J, Li HZ, Ji ZG, Mao QZ, Shi BB, Yan WG.

Urol Ann. 2010 Jan;2(1):12-6. doi: 10.4103/0974-7796.62919.

PMID:
20842251
[PubMed]
Free PMC Article
12.

SDH-related pheochromocytoma and paraganglioma.

Kantorovich V, King KS, Pacak K.

Best Pract Res Clin Endocrinol Metab. 2010 Jun;24(3):415-24. doi: 10.1016/j.beem.2010.04.001. Review.

PMID:
20833333
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Treatment of malignant pheochromocytoma.

Adjallé R, Plouin PF, Pacak K, Lehnert H.

Horm Metab Res. 2009 Sep;41(9):687-96. doi: 10.1055/s-0029-1231025. Epub 2009 Aug 11. Review.

PMID:
19672813
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Phase II study of high-dose [131I]metaiodobenzylguanidine therapy for patients with metastatic pheochromocytoma and paraganglioma.

Gonias S, Goldsby R, Matthay KK, Hawkins R, Price D, Huberty J, Damon L, Linker C, Sznewajs A, Shiboski S, Fitzgerald P.

J Clin Oncol. 2009 Sep 1;27(25):4162-8. doi: 10.1200/JCO.2008.21.3496. Epub 2009 Jul 27.

PMID:
19636009
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

A clinical overview of pheochromocytomas/paragangliomas and carcinoid tumors.

Ilias I, Pacak K.

Nucl Med Biol. 2008 Aug;35 Suppl 1:S27-34. doi: 10.1016/j.nucmedbio.2008.04.007. Review.

PMID:
18707631
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Assessment of the efficacy and toxicity of (131)I-metaiodobenzylguanidine therapy for metastatic neuroendocrine tumours.

Nwosu AC, Jones L, Vora J, Poston GJ, Vinjamuri S, Pritchard DM.

Br J Cancer. 2008 Mar 25;98(6):1053-8. doi: 10.1038/sj.bjc.6604273. Epub 2008 Feb 19.

PMID:
18283308
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk